马萨诸塞州医疗补助 accountable care organization 与儿童哮喘照护差异
该研究利用马萨诸塞州全支付者理赔数据库2014至2020年数据,采用双重差分法比较医疗补助与商业保险哮喘患儿在ACO实施前后(2018年3月)的照护质量与医疗使用。结果显示常规哮喘门诊就诊率差异无显著变化,哮喘药物比例(AMR)大于0.5的比例差异缩小(主要源于商业保险组下降),而医疗补助组任何急诊或住院使用差异扩大。
要点
- ACO实施后医疗补助与商业保险患儿常规哮喘门诊就诊率差异无显著变化。
- AMR大于0.5的比例差异缩小3.7个百分点,但两组绝对水平均下降。
- 医疗补助患儿任何哮喘相关急诊或住院使用差异扩大2.1个百分点。
核心结论
- 马萨诸塞州医疗补助ACO实施与常规哮喘门诊就诊率方面持续的保险相关差异相关。
- AMR适宜率差异缩小,但原因是商业保险组适宜率下降。
- 医疗补助患儿任何急诊或住院使用的差异较商业保险患儿恶化。
研究设计与样本
- 采用双重差分法比较ACO实施(2018年3月)前后各3年医疗补助与商业保险患儿的照护质量与急诊或住院使用。
- 回归模型校正人口学、社区特征与健康状况,共纳入376 509个儿童年观察。
主要发现
- 医疗补助投保儿童年占268 338(71.27%),持续哮喘占73 633(19.56%)。
- 常规哮喘就诊率ACO后医疗补助对商业保险的DiD为-0.4个百分点(95%CI,-1.4至0.6),无显著变化。
- AMR大于0.5比例ACO后医疗补助对商业保险的DiD为3.7个百分点(95%CI,2.0至5.4),两组绝对水平均下降。
- 任何急诊或住院使用ACO后医疗补助对商业保险的DiD为2.1个百分点(95%CI,1.2至3.0),较ACO前医疗补助使用率增加8%。
关键数值与推荐
- 主要结局为日历年内的二分类指标:任何常规哮喘门诊就诊、AMR大于0.5、任何哮喘相关急诊或住院使用。
- 组间描述性统计差异采用χ2检验与t检验判断统计学显著性。
临床怎么用
- 提示医疗补助ACO改革未必自动缩小儿童哮喘照护的保险相关差异,需持续监测门诊、药物与急诊住院指标。
- 评价哮喘照护质量时应同时关注AMR适宜率与急诊或住院使用,避免仅凭单一指标判断改善。
局限性
- 原文未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Nearly 6 million children in the US have asthma, and over one-third of US children are insured by Medicaid. Although 23 state Medicaid programs have experimented with accountable care organizations (ACOs), little is known about ACOs' effects on longstanding insurance-based disparities in pediatric asthma care and outcomes. OBJECTIVE: To determine associations between Massachusetts Medicaid ACO implementation in March 2018 and changes in care quality and use for children with asthma. DESIGN, SETTING, AND PARTICIPANTS: Using data from the Massachusetts All Payer Claims Database from January 1, 2014, to December 31, 2020, we determined child-years with asthma and used difference-in-differences (DiD) estimates to compare asthma quality of care and emergency department (ED) or hospital use for child-years with Medicaid vs private insurance for 3 year periods before and after ACO implementation for children aged 2 to 17 years. Regression models accounted for demographic and community characteristics and health status. Data analysis was conducted between January 2022 and June 2024. EXPOSURE: Massachusetts Medicaid ACO implementation. MAIN OUTCOMES AND MEASURES: Primary outcomes were binary measures in a calendar year of (1) any routine outpatient asthma visit, (2) asthma medication ratio (AMR) greater than 0.5, and (3) any ED or hospital use with asthma. To determine the statistical significance of differences in descriptive statistics between groups, χ2 and t tests were used. RESULTS: Among 376 509 child-year observations, 268 338 (71.27%) were insured by Medicaid and 73 633 (19.56%) had persistent asthma. There was no significant change in rates of routine asthma visits for Medicaid-insured child-years vs privately insured child-years post-ACO implementation (DiD, -0.4 percentage points [pp]; 95% CI, -1.4 to 0.6 pp). There was an increase in the proportion with AMR greater than 0.5 for Medicaid-insured child-years vs privately insured in the postimplementation period (DiD, 3.7 pp; 95% CI, 2.0-5.4 pp), with absolute declines in both groups postimplementation. There was an increase in any ED or hospital use for Medicaid-insured child-years vs privately insured postimplementation (DiD, 2.1 pp; 95% CI, 1.2-3.0 pp), an 8% increase from the preperiod Medicaid use rate. CONCLUSIONS AND RELEVANCE: Introduction of Massachusetts Medicaid ACOs was associated with persistent insurance-based disparities in routine asthma visit rates; a narrowing in disparities in appropriate AMR rates due to reductions in appropriate rates among those with private insurance; and worsening disparities in any ED or hospital use for Medicaid-insured children with asthma compared to children with private insurance. Continued study of changes in pediatric asthma care delivery is warranted in relation to major Medicaid financing and delivery system reforms.
引用
- Geissler KH, Shieh MS, Ash AS, et al. Medicaid Accountable Care Organizations and Disparities in Pediatric Asthma Care. JAMA Pediatr. 2024. PMID: 39348109. doi:10.1001/jamapediatrics.2024.3935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。